Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Company Profile and bullboard matches:

T.GDEP , T.GDPY
Sort by: Date|Relevance

Breaking Down Esports with Enthusiast Gaming's President

Everyone in the investing world is talking about esports, but what's the right away to invest? Omri Wallach of Stockhouse Media hosts this expert interview on the StockTalk Podcast looking at the growing esports market. The goal: understand the hype, and fig...

Olympia Financial Group: With us, it's personal

Olympia Financial Group conducts most of its operations through Olympia Trust Company, providing trust and custodial services to investors in Canada’s private capital markets. The company serves clients from across Canada and is a significant player i...

StockTalk Exclusive! Cannabis Industry Icon Steve DeAngelo

Steve DeAngelo chats with Cindy Broad for the Arcview 2020 Vision Series First Forum: Cannabis Investing for a New Decade. Listen to Steve's colourful commentary on everything from surviving the dip, to what's next for the industry, to his views on psychedelics......

Stemline Shares Take Off on $677 Million Buyout Offer by Global Pharmaceutical Firm

Shares of Stemline Therapeutics traded 150% higher after the company reported that it has entered into a definitive agreement to be acquired by Italy's Menarini Group in a deal valued at up to $677 million. Stemline Therapeutics Inc. (STML:NASDAQ) , which is...

You’re Probably Underinvested in Gold

In a September report, the World Gold Council (WGC) pointed out that some investors are underexposed to gold. The gist of the study is that investors may assume they have adequate exposure to gold because they’re invested in a fund that tracks a broad-ba...

An Urgent Signal for the Coming Bull Market

If you’re new to the markets, it’s easy to get scared of volatility. The media certainly makes it out to be a bad thing. But I believe it’s a landmark moment in an investor’s career when he/she realizes...

Tariffs Are Having a Bigger Effect on U.S. Manufacturing Than Initially Thought

The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...

The growing weaponization of space

In his recent State of the Union address, President Trump gave a shout-out to space exploration, highlighting the newly-created Space Force branch of the US Military, and NASA’s Artemis program of crewed lunar exploration. Artemis aims to put astronauts on ...

Amgen Shares React Favorably to Enbrel Patent Case Victory

Amgen shares are trading 5–6% higher today on news that the company has won its Enbrel (etanercept) patent court case. On Friday, August 9, 2019, Amgen Inc. (AMGN:NASDAQ) announced that it had won its Enbrel patent case. The company advised that the U.S. District C...

Heightened Risk, Easy Money and Gold

In recent months, the World Gold Council released a few interesting reports. What can we learn from the publications? We’ll then supplement it with the view of the Fed policies. Will gold like the message? Gold Demand Trends Q2 2019 On August 1, the WG...
1 2 3 4 5 6 7 8 9